Patents by Inventor Cristin Hubbard

Cristin Hubbard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline form of a ?adrenergic receptor agonist
    Patent number: 7772434
    Abstract: The invention provides a novel ?2 adrenergic receptor agonist in crystalline salt form. The invention also provides pharmaceutical compositions comprising the novel ?2 adrenergic receptor agonist in crystalline salt form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt to treat diseases associated with ?2 adrenergic receptor activity, and processes useful for preparing such crystalline compounds.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: August 10, 2010
    Assignee: Theravance, Inc.
    Inventors: Ioanna Stergiades, Edward Yost, Cristin Hubbard, Weijiang Zhang
  • CRYSTALLINE FORM OF A BETA2 ADRENERGIC RECEPTOR AGONIST
    Publication number: 20100125150
    Abstract: The invention provides a novel ?2 adrenergic receptor agonist in crystalline salt form. The invention also provides pharmaceutical compositions comprising the novel ?2 adrenergic receptor agonist in crystalline salt form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt to treat diseases associated with ?2 adrenergic receptor activity, and processes useful for preparing such crystalline compounds.
    Type: Application
    Filed: May 13, 2009
    Publication date: May 20, 2010
    Applicant: THERAVANCE, INC.
    Inventors: Ioanna Stergiades, Edward Yost, Cristin Hubbard, Weijiang Zhang
  • Crystalline form of beta2 adrenergic receptor agonist
    Publication number: 20070155990
    Abstract: The invention provides a novel ?2 adrenergic receptor agonist in crystalline salt form. The invention also provides pharmaceutical compositions comprising the novel ?2 adrenergic receptor agonist in crystalline salt form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt to treat diseases associated with ?2 adrenergic receptor activity, and processes useful for preparing such crystalline compounds.
    Type: Application
    Filed: January 16, 2007
    Publication date: July 5, 2007
    Inventors: Ioanna Stergiades, Edward Yost, Cristin Hubbard, Weijiang Zhang
  • Crystalline forms of a biphenyl compound
    Publication number: 20060205949
    Abstract: The invention provides crystalline naphthalene-1,5-disulfonic acid salts of biphenyl-2-ylcarbamic acid 1-{2-[5-(4-hydroxybenzylamino)pentylcarbamoyl]ethyl}piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The invention also provides pharmaceutical compositions comprising the crystalline compounds or prepared using such compounds; processes and intermediates for preparing the crystalline compounds; and methods of using the compounds to treat pulmonary disorders.
    Type: Application
    Filed: March 9, 2006
    Publication date: September 14, 2006
    Inventors: Sean Dalziel, Cristin Hubbard, Viengkham Malathong
  • Crystalline form of beta2 adrenergic receptor agonist
    Publication number: 20040248985
    Abstract: The invention provides a novel &bgr;2 adrenergic receptor agonist in crystalline salt form. The invention also provides pharmaceutical compositions comprising the novel &bgr;2 adrenergic receptor agonist in crystalline salt form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt to treat diseases associated with &bgr;2 adrenergic receptor activity, and processes useful for preparing such crystalline compounds.
    Type: Application
    Filed: May 26, 2004
    Publication date: December 9, 2004
    Inventors: Ioanna Stergiades, Edward Yost, Cristin Hubbard, Weijiang Zhang